Back
CNS Pharmaceuticals 10K Form
Sell
34
CNSP
CNS Pharmaceuticals
Last Price:
0.13
Seasonality Move:
-31.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CNSP News And Ratings
See the #1 stock for the next 7 days that we like better than CNSP
CNSP Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-1.65M |
Price / Cash Flow: | 0 |
Annual Sales: | $-2.97 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -124.46730 |
---|---|
Net Income (TTM): | $-15.97M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
CNS Pharmaceuticals Earnings Forecast
Key CNS Pharmaceuticals Financial Ratios
- The Interest Expense is -0.07% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 4 years.
CNS Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | CNSP |
Website: | cnspharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CNSP Technical Analysis vs Fundamental Analysis
Sell
34
CNS Pharmaceuticals (CNSP)
is a Sell
Is CNS Pharmaceuticals a Buy or a Sell?
-
CNS Pharmaceuticals stock is rated a Sell
The current CNS Pharmaceuticals [CNSP] share price is $0.12. The Score for CNSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.